1. Home
  2. PATH vs HALO Comparison

PATH vs HALO Comparison

Compare PATH & HALO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo UiPath Inc.

PATH

UiPath Inc.

N/A

Current Price

$11.62

Market Cap

7.9B

Sector

Technology

ML Signal

N/A

Logo Halozyme Therapeutics Inc.

HALO

Halozyme Therapeutics Inc.

N/A

Current Price

$67.81

Market Cap

8.8B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
PATH
HALO
Founded
2005
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
7.9B
8.8B
IPO Year
2021
2001

Fundamental Metrics

Financial Performance
Metric
PATH
HALO
Price
$11.62
$67.81
Analyst Decision
Hold
Buy
Analyst Count
15
11
Target Price
$15.50
$78.18
AVG Volume (30 Days)
30.1M
1.8M
Earning Date
01-01-0001
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
18.75
N/A
EPS
0.33
2.56
Revenue
$1,429,664,000.00
$151,862,000.00
Revenue This Year
$13.66
$28.24
Revenue Next Year
$9.48
$12.79
P/E Ratio
$35.62
$26.28
Revenue Growth
9.30
N/A
52 Week Low
$9.38
$47.50
52 Week High
$19.84
$82.22

Technical Indicators

Market Signals
Indicator
PATH
HALO
Relative Strength Index (RSI) 47.36 37.52
Support Level $10.42 $63.85
Resistance Level $13.18 $68.00
Average True Range (ATR) 0.56 1.94
MACD 0.28 -0.58
Stochastic Oscillator 82.96 21.55

Price Performance

Historical Comparison
PATH
HALO

About PATH UiPath Inc.

UiPath Inc offers an end-to-end cross-application enterprise automation platform principally with computer vision technology and user interface automations in its initial RPA offering, which remains the foundation of the platform. The platform leverages a range of automation technologies including robotic process automation, application programming interface, and artificial intelligence. UiPath's solution can automate a broad range of repetitive tasks across industries including claims processing, employee onboarding, invoice to cash, loan applications, and customer service.

About HALO Halozyme Therapeutics Inc.

Halozyme Therapeutics Inc is a biotechnology company focused on developing and commercializing novel oncology therapies. The company seeks to create therapies focused on human enzymes that alter tumors. Halozyme focuses on developing its proprietary products in therapeutic areas with a focus on oncology, and licensing its technology to biopharmaceutical companies to collaboratively develop products. The company's operations are based in the United States, with minimal long-lived assets located internationally.

Share on Social Networks: